4.92
price up icon2.71%   0.13
pre-market  Pre-mercato:  4.91   -0.010   -0.20%
loading
Precedente Chiudi:
$4.79
Aprire:
$4.75
Volume 24 ore:
4.31M
Relative Volume:
1.17
Capitalizzazione di mercato:
$1.17B
Reddito:
$251.85M
Utile/perdita netta:
$-72.58M
Rapporto P/E:
-41.00
EPS:
-0.12
Flusso di cassa netto:
$-63.80M
1 W Prestazione:
+9.33%
1M Prestazione:
-15.75%
6M Prestazione:
-37.96%
1 anno Prestazione:
+12.33%
Intervallo 1D:
Value
$4.68
$4.96
Intervallo di 1 settimana:
Value
$4.43
$5.06
Portata 52W:
Value
$4.06
$10.13

Ardelyx Inc Stock (ARDX) Company Profile

Name
Nome
Ardelyx Inc
Name
Telefono
510-745-7047
Name
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Name
Dipendente
267
Name
Cinguettio
@ardelyx
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
ARDX's Discussions on Twitter

Confronta ARDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ARDX 4.92 1.17B 251.85M -72.58M -63.80M -0.12
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-02 Downgrade Piper Sandler Overweight → Neutral
2024-04-05 Iniziato Leerink Partners Outperform
2023-12-18 Iniziato Raymond James Strong Buy
2023-09-07 Iniziato H.C. Wainwright Buy
2023-08-25 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2023-03-03 Aggiornamento Wedbush Neutral → Outperform
2022-11-17 Aggiornamento Piper Sandler Neutral → Overweight
2022-05-06 Downgrade Cantor Fitzgerald Overweight → Neutral
2021-12-01 Aggiornamento Ladenburg Thalmann Neutral → Buy
2021-10-14 Downgrade Ladenburg Thalmann Buy → Neutral
2021-07-21 Downgrade Jefferies Buy → Hold
2021-07-20 Downgrade Piper Sandler Overweight → Neutral
2021-07-20 Downgrade Wedbush Outperform → Neutral
2021-03-23 Iniziato Wedbush Outperform
2021-01-06 Iniziato Cantor Fitzgerald Overweight
2020-10-20 Ripresa Citigroup Buy
2020-02-18 Ripresa Jefferies Buy
2020-02-12 Iniziato Citigroup Buy
2020-02-10 Iniziato Cowen Outperform
2019-04-08 Iniziato Piper Jaffray Overweight
2018-08-24 Iniziato Jefferies Buy
2018-03-19 Ripresa Leerink Partners Outperform
2017-11-29 Reiterato Citigroup Buy
2017-11-22 Reiterato Ladenburg Thalmann Buy
2017-10-17 Ripresa Leerink Partners Outperform
2016-03-31 Iniziato Ladenburg Thalmann Buy
2016-03-09 Iniziato Cantor Fitzgerald Buy
2016-03-03 Iniziato Citigroup Buy
Mostra tutto

Ardelyx Inc Borsa (ARDX) Ultime notizie

pulisher
Nov 20, 2024

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Ardelyx Executives to Present at Piper Sandler Healthcare Conference | ARDX Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Jefferies optimistic on Ardelyx stock as management navigates reimbursement changes - Investing.com

Nov 20, 2024
pulisher
Nov 18, 2024

US Penny Stocks To Monitor In November 2024 - Simply Wall St

Nov 18, 2024
pulisher
Nov 18, 2024

Ardelyx, Inc. (NASDAQ:ARDX) Short Interest Up 5.1% in October - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Ardelyx, Inc. (NASDAQ:ARDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 17, 2024
pulisher
Nov 15, 2024

Ardelyx (NASDAQ:ARDX) Shares Gap UpTime to Buy? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Janus Henderson Group PLC's Strategic Reduction in Ardelyx Inc H - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Director David Mott Acquires 215,868 Shares of Ardelyx Inc (ARDX) - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability (NASDAQ:ARDX) - Seeking Alpha

Nov 14, 2024
pulisher
Nov 13, 2024

HC Wainwright Has Bearish Forecast for Ardelyx Q1 Earnings - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Ardelyx (NASDAQ:ARDX) Rating Lowered to “Neutral” at HC Wainwright - Defense World

Nov 13, 2024
pulisher
Nov 11, 2024

Ardelyx shares downgraded amid sales concerns for XPHOZAH By Investing.com - Investing.com Australia

Nov 11, 2024
pulisher
Nov 11, 2024

Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop - Seeking Alpha

Nov 11, 2024
pulisher
Nov 11, 2024

Ardelyx (NASDAQ:ARDX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Ardelyx shares downgraded amid sales concerns for XPHOZAH - Investing.com India

Nov 11, 2024
pulisher
Nov 11, 2024

Ardelyx (NASDAQ:ARDX) Lowered to Neutral Rating by HC Wainwright - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Ardelyx chief development officer sells shares worth $165,743 - Investing.com India

Nov 09, 2024
pulisher
Nov 09, 2024

Ardelyx chief development officer sells shares worth $165,743 By Investing.com - Investing.com Australia

Nov 09, 2024
pulisher
Nov 08, 2024

David P. Rosenbaum Sells 27,171 Shares of Ardelyx, Inc. (NASDAQ:ARDX) Stock - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx Beats Q3 Sales Estimates, Shares Climb - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx Loses Bid to Block HHS Classification of Kidney Drug - Bloomberg Law

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx tumbles as lawsuit against CMS dismissed over Xphozah (update) - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx Responds to District Court Decision Granting Motion to Dismiss - The Manila Times

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx (NASDAQ:ARDX) Shares Gap DownTime to Sell? - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx ‘disappointed’ by court decision granting motion to dismiss - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx Stock Alert: Court Dismisses CMS Lawsuit, XPHOZAH Access Concerns Mount | ARDX Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 08, 2024

Ardelyx falls after court dismisses lawsuit against CMS over company's kidney disease drug - XM

Nov 08, 2024
pulisher
Nov 06, 2024

Ardelyx chief development officer sells $161,673 in stock - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Ardelyx chief development officer sells $161,673 in stock By Investing.com - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

(ARDX) Investment Analysis - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 06, 2024

Citigroup Lowers Ardelyx (NASDAQ:ARDX) Price Target to $10.00 - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference - ForexTV.com

Nov 05, 2024
pulisher
Nov 05, 2024

Ardelyx (ARDX) Leadership to Present at Jefferies London Healthcare Conference 2024 | ARDX Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

What is Wedbush’s Forecast for Ardelyx FY2026 Earnings? - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Inve - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Ardelyx (NASDAQ:ARDX) Price Target Lowered to $10.00 at Citigroup - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Wedbush Has Negative Outlook for Ardelyx FY2026 Earnings - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Ardelyx, Inc. (NASDAQ:ARDX) Q3 2024 Earnings Call Transcript - MSN

Nov 03, 2024
pulisher
Nov 03, 2024

Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Simply Wall St

Nov 03, 2024
pulisher
Nov 03, 2024

Ardelyx (NASDAQ:ARDX) Stock Price Up 7.3% – Here’s Why - Defense World

Nov 03, 2024
pulisher
Nov 03, 2024

Allspring Global Investments Holdings LLC Sells 19,212 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seekin - GuruFocus.com

Nov 02, 2024
pulisher
Nov 02, 2024

Ardelyx Third Quarter 2024 Earnings: US$0.003 loss per share (vs US$0.03 profit in 3Q 2023) - Yahoo Finance

Nov 02, 2024
pulisher
Nov 02, 2024

Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Ardelyx (NASDAQ:ARDX) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Ardelyx reports solid growth amid Medicare challenges - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Earnings call: Ardelyx reports solid growth amid Medicare challenges By Investing.com - Investing.com Canada

Nov 01, 2024
pulisher
Nov 01, 2024

Ardelyx (NASDAQ:ARDX) Shares Up 7.3%Should You Buy? - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Ardelyx Target of Unusually High Options Trading (NASDAQ:ARDX) - MarketBeat

Nov 01, 2024

Ardelyx Inc Azioni (ARDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
Capitalizzazione:     |  Volume (24 ore):